price
RE
NASDAQ · REPL
Replimune Group, Inc.
Healthcare · Biotechnology
$11.99
Up+$0.27 (+2.30%)
Updated Oct 23, 2026, 10:49 AM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 774.6M
- P/E ratio
- -3.23
- Dividend yield
- 0.00%
- 52-week range
- $1.50 – $16.33
- Volume
- 1.76M
- Avg. volume
- 5.08M
Price performance · REPL
REPL price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 22, 2026
REPL closed at $11.99 after 21 trading sessions, down 4.84% for the selected period.
- Last close
- $11.99
- Period change
- -4.84%
- Period low
- $10.86
- Period high
- $13.45
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 22, 2026 | $11.70 | $12.01 | $11.5293 | $11.99 | 1.76M |
| Oct 21, 2026 | $11.37 | $12.045 | $11.31 | $11.72 | 2.2M |
| Oct 20, 2026 | $11.04 | $11.69 | $10.995 | $11.42 | 1.39M |
| Oct 19, 2026 | $11.03 | $11.225 | $10.67 | $11.05 | 1.54M |
| Oct 16, 2026 | $11.73 | $11.73 | $10.805 | $10.86 | 1.71M |
| Oct 15, 2026 | $11.32 | $11.86 | $11.2314 | $11.75 | 1.61M |
| Oct 14, 2026 | $12.05 | $12.37 | $11.37 | $11.39 | 1.86M |
| Oct 13, 2026 | $12.91 | $12.93 | $12.07 | $12.11 | 1.63M |
| Oct 12, 2026 | $13.21 | $13.56 | $12.97 | $13.07 | 1.16M |
| Oct 9, 2026 | $12.96 | $13.44 | $12.79 | $13.42 | 2.02M |
| Oct 8, 2026 | $13.18 | $13.46 | $12.85 | $13.04 | 1.75M |
| Oct 7, 2026 | $13.14 | $13.60 | $13.01 | $13.20 | 1.65M |
| Oct 6, 2026 | $13.17 | $13.51 | $12.87 | $13.25 | 2.62M |
| Oct 5, 2026 | $13.14 | $13.29 | $12.51 | $13.15 | 2.28M |
| Oct 2, 2026 | $13.69 | $13.83 | $12.80 | $13.07 | 1.3M |
| Oct 1, 2026 | $13.26 | $13.59 | $13.055 | $13.45 | 2.52M |
| Sep 30, 2026 | $12.99 | $13.658 | $12.65 | $13.24 | 3.08M |
| Sep 29, 2026 | $12.44 | $13.42 | $12.35 | $13.00 | 4.37M |
| Sep 28, 2026 | $12.15 | $12.7572 | $12.07 | $12.56 | 1.97M |
| Sep 25, 2026 | $12.63 | $12.80 | $12.30 | $12.36 | 1.65M |
| Sep 24, 2026 | $12.87 | $12.8795 | $12.07 | $12.60 | 2.58M |
Latest REPL news
The latest Smart Investors Daily articles mentioning REPL.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…

